Jeil Pharmaceutical Co., Ltd.

Industry

  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology

Other Names/Subsidiaries

  • Pharmaceutical Co
  • Onconic Therapeutics
See more in Biomedtracker

Latest on Jeil Pharmaceutical Co., Ltd.

Scrip

Pickup In Korea Biopharma IPO Activity Signals Improving Investor Sentiment

 
• By Jung Won Shin

A series of initial public offering plans unveiled by South Korean biopharma firms, notably Orum Therapeutics Inc., is raising hopes of a recovery in the general funding situation in the sector. After

Scrip

Asia Deal Watch: Avenue Takes On AnnJi’s Spinal And Bulbar Muscular Atrophy Candidate

 
• By Dexter Jie Yan, Lisa Takagi, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. AnnJi Licenses Muscular Atrophy Ca

Scrip

Shionogi Reveals Strategy For COVID-19 Drug Xocova

 
• By Lisa Takagi

Shionogi & Co. Ltd. has updated the development strategy for its oral COVID-19 therapeutic drug Xocova (ensitrelvir; S-217622) after its approval was twice put on hold by the Japanese government. Whi

Scrip

Deal Watch: Cidara Licenses US Rights To Antifungal Under FDA Review To Melinta

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cidara Hopes For Early 2023 Approval Of